Published on
UCD National Virus Reference Laboratory
(
https://nvrl.ucd.ie
)
Home
> NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient
posted by
Anonymous
on
23 June 2016
NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient
Sevastianova K, Dean J, Bannan C, Coghlan M, Farrell G, Murray C, De Gascun CF, Bergin C
J Clin Virol. 2016 Sep;82:66-69
10.1016/j.jcv.2016.06.012
Source URL:
https://nvrl.ucd.ie/node/175